JR
Jamie L. Reynoso
CEO, Medicare Advantage

Jamie L. Reynoso insider trades: Clover Health Investments (CLOV) stock sales

CEO, Medicare Advantage, Clover Health Investments Last trade Oct 19, 2026 69 Form 4 filings
$449K
Sold, last 12 months
17 sales
$0
Bought, last 12 months
0 buys
24
Open-market trades
since 2025
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jamie reports to the SEC

Open-market buys and sales

24 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 19, 2026CLOV↓ Sell10b5-1$18K
Oct 15, 2026CLOV↓ Sell$86K
Oct 7, 2026CLOV↓ Sell10b5-1$9K
Oct 5, 2026CLOV↓ Sell$39K
Sep 17, 2026CLOV↓ Sell10b5-1$9K
Sep 15, 2026CLOV↓ Sell$44K
Jul 17, 2026CLOV↓ Sell10b5-1$22K
Jul 15, 2026CLOV↓ Sell$61K
Jul 8, 2026CLOV↓ Sell10b5-1$11K
Jul 6, 2026CLOV↓ Sell$33K
Jun 17, 2026CLOV↓ Sell10b5-1$11K
Jun 15, 2026CLOV↓ Sell$29K
Jun 11, 2026CLOV↓ Sell10b5-1$36K
Mar 18, 2026CLOV↓ Sell10b5-1$11K
Jan 20, 2026CLOV↓ Sell10b5-1$12K
Jan 7, 2026CLOV↓ Sell10b5-1$5K
Dec 18, 2025CLOV↓ Sell10b5-1$13K
Nov 4, 2025CLOV↓ Sell10b5-1$109K
Oct 17, 2025CLOV↓ Sell10b5-1$44K
Oct 7, 2025CLOV↓ Sell10b5-1$5K
Sep 17, 2025CLOV↓ Sell10b5-1$15K
Aug 4, 2025CLOV↓ Sell10b5-1$20K
Jul 7, 2025CLOV↓ Sell10b5-1$57K
Jun 17, 2025CLOV↓ Sell10b5-1$58K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CLOV insiders

Open-market trades in the last 12 months

About Jamie L. Reynoso's insider trades

Jamie L. Reynoso is CEO, Medicare Advantage at Clover Health Investments (CLOV). Since Jun 17, 2025, Jamie has reported no open-market purchases and 24 sales worth $758K on SEC Form 4. In the last 12 months: 17 sales ($449K).

18 sales (61% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include shares withheld for taxes (39 filings), grants and awards (13 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLOV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.